INSIGHTS
September 23, 2019

One size doesn’t fit all đź’Š

Digital solutions are changing how medications are delivered—from precision drug dosing to rightsizing regimens. To that end, we’re excited to share our two newest investments: InsightRX and Arine. InsightRX enables clinicians to individualize treatment at the point of care—helping identify not only the right drug for the right patient, but also the right dose at the right time. And Arine generates timely, personalized recommendations to ensure patients are on the safest and most effective meds. We’re honored to welcome their teams to the Rock Health family!

Are you building a company to drastically improve the patient journey while cutting costs and improving outcomes? We’d love to hear from you.

Headlines

Medications Managed: Our Investment In Arine
Arine optimizes meds via data-driven clinical expertise Rock Health | (Tweet)

InsightRX Gets $10M To Personalize Drug Doses
Because “one size fits all” doesn’t cut it in drug treatment Forbes | (Tweet)

Build Vs. Buy: What Should Health Systems Do?
Full stack tech-enabled clinical services are showing promise NEJM Catalyst | (Tweet)

Fitbit Is Exploring A Sale
+ One of its wearables may have been the sole witness in a 2018 murder CNBC | (Tweet)

Google Completes Its Controversial DeepMind Takeover
Privacy concerns tied to the company’s healthcare ambitions aren’t new TechCrunch | (Tweet)

Mental Health Apps Are Scooping Up Your Most Sensitive Data
Patient privacy may be at risk—with marginal or unknown benefits STAT | (Tweet)

Walgreens To Test Drone Delivery With Alphabet
Together, they’ll deliver basic health necessities within minutes CNBC | (Tweet)

Recent Funding